[1]
Iqbal Anand, M. et al. 2022. SGLT2 INHIBITORS DECREASE CARDIOVASCULAR DEATH AND HEART FAILURE HOSPITALIZATIONS: A SYSTEMATIC REVIEW. Journal of Advanced Research in Medical and Health Science (ISSN 2208-2425). 8, 11 (Nov. 2022), 7–13. DOI:https://doi.org/10.53555/nnmhs.v8i11.1398.